This is a preview of subscription content, log in via an institution to check access.
References
Alvarado MD, et al. Cost-effectiveness of gene expression profiling for ductal carcinoma in-situ (Oncotype DCIS Score). 35th Annual San Antonio Breast Cancer Symposium : abstr. P5-15-01, 4 Dec 2012.
Yamauchi H, et al. Societal economics of the 21-gene Recurrence Score(R) in estrogen-receptor-positive early-stage breast cancer in Japan. 35th Annual San Antonio Breast Cancer Symposium : abstr. P5-15-06, 4 Dec 2012.
Rights and permissions
About this article
Cite this article
Genetic testing worthwhile to guide breast cancer treatment. PharmacoEcon Outcomes News 670, 6 (2013). https://doi.org/10.1007/s40274-013-0094-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0094-2